Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finke

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
Blood Advances|January 4, 2018
Targeted deep sequencing in primary myelofibrosisAyalew Tefferi, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|August 29, 2018
Mutations and karyotype predict treatment response in myelodysplastic syndromesDame Idossa, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|December 6, 2018
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosisAyalew Tefferi, Terra L Lasho, Mythri Mudireddy, et al.
Blood|September 13, 2012
SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survivalTerra L Lasho, Thitina Jimma, Christy M Finke, et al.
Mayo Clinic Proceedings|November 17, 2004
Autopsy results after surgery for non-small cell lung cancerNicole M Finke, Marie-Christine Aubry, Henry D Tazelaar, et al.
Leukemia|November 9, 2011
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patientsT L Lasho, C M Finke, C A Hanson, et al.
American Journal of Hematology|October 13, 2016
DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemiaMrinal M Patnaik, Daniela Barraco, Terra L Lasho, et al.
Medicine and Science in Sports and Exercise|January 6, 2005
Erosive effect of a new sports drink on dental enamel during exerciseMichelle C Venables, Linda Shaw, Asker E Jeukendrup, et al.
Blood Cancer Journal|January 16, 2016
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemiaM M Patnaik, T L Lasho, P Vijayvargiya, et al.
Leukemia|September 14, 2011
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617FA Tefferi, T Jimma, N H Sulai, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Blood Advances|January 4, 2018
Targeted deep sequencing in primary myelofibrosisAyalew Tefferi, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|August 29, 2018
Mutations and karyotype predict treatment response in myelodysplastic syndromesDame Idossa, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|December 6, 2018
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosisAyalew Tefferi, Terra L Lasho, Mythri Mudireddy, et al.
Blood|September 13, 2012
SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survivalTerra L Lasho, Thitina Jimma, Christy M Finke, et al.
Mayo Clinic Proceedings|November 17, 2004
Autopsy results after surgery for non-small cell lung cancerNicole M Finke, Marie-Christine Aubry, Henry D Tazelaar, et al.
Leukemia|November 9, 2011
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patientsT L Lasho, C M Finke, C A Hanson, et al.
American Journal of Hematology|October 13, 2016
DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemiaMrinal M Patnaik, Daniela Barraco, Terra L Lasho, et al.
Medicine and Science in Sports and Exercise|January 6, 2005
Erosive effect of a new sports drink on dental enamel during exerciseMichelle C Venables, Linda Shaw, Asker E Jeukendrup, et al.
Blood Cancer Journal|January 16, 2016
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemiaM M Patnaik, T L Lasho, P Vijayvargiya, et al.
Leukemia|September 14, 2011
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617FA Tefferi, T Jimma, N H Sulai, et al.
Pageof 18